The mRNA and protein expression of ANXA2 is lower in only 22 ESCC tumor cells in the patient tissues than that in its paired normal counterpart [95], and this downregulation is significantly correlated with lymphoid node metastasis (P < 0.05) and pathological differentiation (P < 0.05) [94]. Here, ANXA2 is linked to neoplasm.